Hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy is a primary myocardial disorder with an autosomal dominant pattern of inheritance, characterized by an asymmetric thickening (hypertrophy) of the muscle of the left ventricle. In approximately 25% of patients there is a narrowing (obstruction) of the left ventricular outflow tract. The estimated prevalence of HCM in the general population is 1 in 500. Men and women are equally affected. Most patients are asymptomatic. Shortness of breath, chest pain, palpitations or fainting may occur. Exercise-dependent cardiac arrhythmias can lead to sudden death. Athletes with HCM are generally discouraged from competitive sports. 

Contact person


Dr. med. Philipp Bohm


Tel.: +49 (0)681 302-70400

Fax: +49 (0)681 302-4296


Institut für Sport- und Präventivmedizin 

Saarland University

Campus B8 2

66123 Saarbrücken